NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NYSE · Health Information Services · USD

Evolent Health, Inc. (EVH) Stock Analysis

Evolent Health, Inc. (EVH) is a Health Information Services stock listed on NYSE and quoted in US Dollar.

EVH

$4.32

+$0.06 (+1.41%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare EVH with… →

EVH Key Statistics

As of Sep 4, 2026
Trading
Open
$4.23
Previous Close
$4.26
Day's Range
4.15–4.35
52-Week Range
2.10–10.08
Volume
1.73M
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.84
Valuation
Market Cap
$488.42M
P/E Ratio
unprofitable
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
11.05
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
1.93
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
0.23
EPS (ttm)Profit attributable to each share over the last twelve months.
−4.49
Financials (FY)
Revenue (FY)
$1.88B−26.56%
Net Income (FY)
−$534.51M
Profit marginThe share of revenue left as profit after all costs and taxes.
−24.08%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
113.06M
1-Year Return
−54.48%
Dividend and dates
Earnings Date
November 5, 2026estimated
Avg Volume
3.09M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

EVH Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+8.00%
2025−64.44%
2024−65.94%
2023+17.63%
2022+1.48%
2021+72.61%
2020+77.13%
2019−54.64%
2018+62.20%
2017−16.89%
2016 (partial year)−42.30%

As of September 4, 2026.

EVH Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$1.88B−$534.51M−28.5%
2024$2.55B−$61.62M−2.4%
2023$1.96B−$113.04M−5.8%
2022$1.35B−$19.16M−1.4%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$1.88B$399.88M−$19.83M−$534.51M−28.5%
2024$2.55B$367.35M−$14.07M−$61.62M−2.4%
2023$1.96B$460.47M−$21.06M−$113.04M−5.8%
2022$1.35B$316.58M−$19.88M−$19.16M−1.4%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

EVH Valuation vs Health Information Services Median

Median of 53 stocks
MetricEVHHealth Information Services medianvs median
P/S ratio0.232.660.1x the median
Profit margin−24.08%0.00%24.1 pts below

Medians across 53 Health Information Services stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

All 20 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Evolent Health, Inc. (EVH) carries a market capitalisation of $488.42M. The company sits in the Healthcare sector, in the Health Information Services industry. Headcount on file is 4,200.

The most recent close on file for EVH is $4.32, dated September 4, 2026. That is +$0.06 (+1.41%) against the previous close. The 52-week range on file runs from $2.10 to $10.08. The latest close sits 106.21% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $1.88B. That is −26.56% against the prior fiscal year, when revenue was $2.55B. The same year closed with a net loss of $534.51M. Profit margin runs at −24.08%. That is 24.1 percentage points below the Health Information Services median of 0%. Earnings per share on a trailing basis come to −4.49.

Across the 4 fiscal years on file, revenue moves from $1.35B in 2022 to $1.88B in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

No trailing P/E applies: the last reported earnings figure is negative. The forward P/E on file is 11.05. The PEG ratio, which sets the P/E against expected earnings growth, reads 1.93. The price-to-sales ratio is 0.23. On price-to-sales that is 0.1 times the Health Information Services median of 2.66. The medians here are taken across 53 Health Information Services companies that report the metric.

The reported beta is 0.84. Annualized volatility over the trailing 10 years is 63.81%. The trailing one-year price return is −54.48%. Across 10 years the annualized return works out at −16.08%.

Growth & Income

The record shows no dividend for EVH.

2026 is still running; the price is +8.00% year to date. Across the complete calendar years on file, 2020 returned +77.13% and 2024 returned −65.94%. Of the 9 complete calendar years on file, 5 finished higher.

Peer Comparison

Evolent Health, Inc. (EVH) operates in the Health Information Services industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Evolent Health, Inc. EVH $488.42M —
Veeva Systems Inc. VEEV $44.54B 45.0
BrightSpring Health Services, Inc. BTSG $12.02B 54.7
Tempus AI, Inc. TEM $11.66B —

The Health Information Services industry average P/E ratio is 41.1x. Evolent Health, Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Health Information Services Stocks

VEEV

Veeva Systems Inc.

$44.54B

 BTSG

BrightSpring Health Services, Inc.

$12.02B

 TEM

Tempus AI, Inc.

$11.66B

 HQY

HealthEquity, Inc.

$7.95B

 HNGE

Hinge Health, Inc.

$7.45B

 WAY

Waystar Holding Corp.

$4.81B
View all Health Information Services stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 UNH

UnitedHealth Group Incorporated

$356.47B
View all Healthcare stocks →

About Evolent Health, Inc.

Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated value-based care platform for health plan administration and management. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides Machinify Auth Intelligence, an artificial intelligence tool to aid nurses and physicians in completing clinical review of prior authorization requests. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.

Visit website →